Peter Lynch fit · Growth at a reasonable price (GARP)
Is Arrowhead Pharmaceuticals, Inc. (ARWR) a Peter Lynch Stock?
Strong GARP candidate - growth at a reasonable price.
75/100
BProbable acción Lynch
4/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a ARWR
PEG ≤ 1.0
clave-
EPS CAGR ≥ 15%
clave-
Revenue CAGR ≥ 10%
56.5%
Net margin > 0
18.5%
Cómo se valora ARWR en otras estrategias
Datos financieros en vivo
Cap. mercado
$10.56B
PER (TTM)
-
ROIC (TTM)
-10.98%
Margen bruto
98.98%
Otros análisis Peter Lynch
Preguntas frecuentes
What is ARWR's Peter Lynch fit score?
ARWR scores 75/100 on our Peter Lynch fit engine - grade B. Strong GARP candidate - growth at a reasonable price.
Does Peter Lynch actually own ARWR?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends ARWR.
How often is this score updated?
ARWR's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende ARWR personalmente.